Skip to content

PHARMALAW

Active
Private limited companyfounded 20188 yrs activeBeukenlaan 7, 3080 Tervuren, BelgiumKBO/BCE: BE 0700.871.124

PHARMALAW has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €434k and a net result of €178k. Equity is growing by ~23% per year across the filed fiscal years. Its solvency ranks better than 60% of 12642 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
92 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+11
Solvency91▼-9
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity ample (current ratio 2.92 against 8.69 in 2024; short-term debt: 34.2% and cash: 68.2% of total assets), and 34.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 69
Relative position
BE, all sectors
reference
Sector 69
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
65.8%
Return on assets
27%
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 8 years 0 10 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
14 d early
2024
26 d late
2023
6 d early
2022
3 d early
2021
23 d late
2020
27 d late
2019
28 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€434k▼ 29.4%
2024 · €614k
2019: €114k 2020: €241k 2021: €357k 2022: €479k 2023: €609k 2024: €614k
2019 → 2025
Total assets
€659k▼ 5.0%
2024 · €694k
2019: €189k 2020: €350k 2021: €463k 2022: €551k 2023: €651k 2024: €694k
2019 → 2025
Net result
€178k▲ 58.1%
2024 · €112k
2019: €108k 2020: €127k 2021: €116k 2022: €122k 2023: €130k 2024: €112k
2019 → 2025
Working capital
€433k▼ 29.3%
2024 · €612k
2019: €114k 2020: €240k 2021: €355k 2022: €473k 2023: €605k 2024: €612k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€357k-€479k▲ 34.2%€609k▲ 27.2%€614k▲ 0.8%€434k▼ 29.4%
Operating result€164k-€174k▲ 6.2%€171k▼ 1.4%€147k▼ 14.4%€256k▲ 74.3%
Net result€116k-€122k▲ 5.4%€130k▲ 6.7%€112k▼ 13.7%€178k▲ 58.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200k€300kOperating result 2021: €164k€164kNet result 2021: €116k€116kOperating result 2022: €174k€174kNet result 2022: €122k€122kOperating result 2023: €171k€171kNet result 2023: €130k€130kOperating result 2024: €147k€147kNet result 2024: €112k€112kOperating result 2025: €256k€256kNet result 2025: €178k€178k20212022202320242025
The operating result recovers in 2025; 2025 is 74% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €659k
Fixed assets €1k▼ 52.1%
Current assets €658k▼ 4.8%
Equity and liabilities €659k
Equity €434k▼ 29.4%
Debt €225k▲ 183%
The debt ratio rises from 11.5% to 34.2%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€257k
2024 · €148k
Cash flow
€179k
2024 · €114k
Solvency
65.8%
2024 · 88.5%
Current ratio
2.92
2024 · 8.69
Quick ratio
2.92
2024 · 8.69
Debt / equity
0.52
2024 · 0.13
ROE
41.0%
2024 · 18.3%
ROA
27.0%
2024 · 16.2%
Interest coverage
22.74
2024 · 31.88
Debt
€225k
2024 · €80k
Debt ≤ 1 year
€225k
2024 · €80k
Income taxes
€77k
2024 · €47k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€694k€659k
Fixed assets21/28€2k€1k
Tangible fixed assets22/27€2k€1k
Plant, machinery and equipment23€414€0
Furniture and vehicles24€2k€1k
Current assets29/58€691k€658k
Amounts receivable within one year40/41€234k€58k
Trade receivables40€0€49k
Other amounts receivable41€234k€10k
Current investments50/53€106k€142k
Cash at bank and in hand54/58€349k€450k
Deferred charges and accrued income490/1€3k€8k
Equity and liabilities
Total equity and liabilities10/49€694k€659k
Equity10/15€614k€434k
Contributions10/11€6k€6k=
Reserves13€608k€428k
Distributable reserves133€608k€428k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€80k€225k
Amounts payable within one year42/48€80k€225k
Trade debts44€11k€11k
Suppliers440/4€11k€11k
Taxes, remuneration and social security45€1k€93k
Taxes450/3€1k€93k
Other amounts payable47/48€67k€121k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€1k
Other operating charges640/8-€458
Gross operating margin9900€148k€257k
Operating profit (loss)9901€147k€256k
Financial income75/76B€17k€24k
Recurring financial income75€17k€24k
Financial charges65/66B€5k€25k
Recurring financial charges65€5k€11k
Non-recurring financial charges66B-€14k
Profit (loss) for the period before taxes9903€159k€254k
Income taxes67/77€47k€77k
Profit (loss) for the period9904€112k€178k
Profit (loss) for the period to be appropriated9905€112k€178k
Appropriation of the result
Profit (loss) to be appropriated9906€112k€178k
Transfer from equity791/2€108k€358k
Transfer to equity691/2€112k€178k
To other reserves6921€112k€178k
Profit to be distributed694/7€108k€358k
Return on contributions (dividend)694€108k€358k

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
17-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Highest result since 2019net €178k ▲58.1%
Operating result €256k, net result €178k, both a record.
26-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 26 days late
2024
25-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Liquidity doublescurrent ratio 15.64
Current ratio from 7.60 to 15.64; short-term debt falls from €72k to €41k.
31-12
Financial Equity above €500kEq €609k ▲27.2%
5 profitable years in a row build equity to €609k.
28-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
23-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 23 days late
2021
27-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 27 days late
2020
31-12
Financial Equity above €200kEq €241k ▲111%
2 profitable years in a row build equity to €241k.
28-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tervuren · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Beukenlaan 73080 Tervuren
Ground area
988 m²
Building footprint
124 m²
Volume, LiDAR
936 m³
Parcel 24302F0075/00N002, Flanders · tallest building 10.2 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Beukenlaan 7, 3080 Tervuren
Business consulting
since 20182.278.489.319
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24302F0075/00N002 Flanders 988 m² 1 · 124 m² 10.2 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

875500EDA76QQQKQ4W26
live in the LEI register

Similar companies · same sector, comparable size

Of 2,761 companies in sector 69109 we hold annual accounts for 1,209. 775 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded14-08-2018
Fiscal year end31-12
Activities, NACEBEL
69109Other legal services
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers

Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.